The Safety and Clinical Efficacy of Pollinex -R and Pollinex Quattro Ragweed Assessed in an Environmental Exposure Chamber
The benefit-risk balance of subcutaneous immunotherapy (SCIT) for seasonal allergic rhinitis (SAR)
Serious adverse events and the incidence of anaphylaxis in specific immunotherapy (SIT) preparations
Improvement in quality of life for patients with tree pollen-related rhinoconjunctivitis and asthma after ultra short course specific immunotherapy (uSCIT) Pollinex Quattro (PQ)
Comparison of outcomes following ultra short course specific immunotherapy (uSCIT) in juvenile and adult patients with asthma
Comparison of efficacy of conventional subcutaneous immunotherapy (SCIT, Ultra short SCIT (uSCIT), and sublingual immunotherapy (SLIT): results of a multicentre observational study
Pollinex Quattro (PQ) Grass immunotherapy treatment promotes beneficial immune responses in a patients independent of their skin prick test (SPT) sensitivity and IgG status at baseline
